Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
VA Plans Future EHR Deployment on Facility Relationships
VA’s EHR program is expected to restart in 2026 and will plan deployment based on pre-existing relationships between facilities to drive interoperability.
21m watch -
Trump Overhauls Federal Cybersecurity with New Executive Order
The new directive aims to strengthen digital defenses while rolling back "burdensome" software requirements and refocusing AI security.
3m read -
DOE Accelerates AI Research to Defend Critical Infrastructure
The Energy Department and its national labs are increasing partnerships to advance AI research, scale new tools and boost national security.
3m read -
AI Revolutionizes Defense Decision-Making
AI enhances access to vital information for defense leaders, empowering faster, more informed decision-making on and off the battlefield.
29m watch
